Vident Investment Advisory’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,967
Closed -$1.35M 1149
2021
Q2
$1.35M Sell
22,967
-702
-3% -$43.4K 0.04% 564
2021
Q1
$1.54M Buy
23,669
+1,517
+7% +$93.2K 0.05% 485
2020
Q4
$1.22M Sell
22,152
-1,292
-6% -$65.9K 0.05% 486
2020
Q3
$1.03M Sell
23,444
-16,081
-41% -$707K 0.05% 478
2020
Q2
$1.67M Sell
39,525
-6,365
-14% -$245K 0.09% 259
2020
Q1
$1.82M Sell
45,890
-7,826
-15% -$331K 0.12% 196
2019
Q4
$2.39M Buy
+53,716
New +$2.07M 0.15% 199
2019
Q2
Sell
-24,804
Closed -$758K 439
2019
Q1
$758K Sell
24,804
-621
-2% -$19K 0.04% 466
2018
Q4
$704K Buy
+25,425
New +$699K 0.04% 499

Other funds holding ACA

Vident Investment Advisory's ACA Position: Q3 2021 in Review

Vident Investment Advisory sold out of Arcosa (ACA) in Q3 2021, closing a stake of 22,967 shares — an estimated $1.35M sold.

Vident Investment Advisory first reported a position in ACA in Q4 2018 and held it in 9 quarters. The position peaked at $2.39M in Q4 2019. 248 funds tracked by Wall St. Rank hold ACA as of Q3 2021.

  • Vident Investment Advisory reported no remaining Arcosa position as of Q3 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 22,967 Arcosa shares in Q3 2021, an estimated $1.35M.
  • Vident Investment Advisory first reported a position in Arcosa in Q4 2018 and held it in 9 quarters.
  • Vident Investment Advisory's Arcosa position peaked at $2.39M in Q4 2019.
  • 248 funds tracked by Wall St. Rank held Arcosa as of Q3 2021.

Based on Vident Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.